Product Information
DESIPRAMINE 50 MG TABLET is a generic product labeled by Ingenus Pharmaceuticals LLC, priced at $0.2177 per EA under NDC 50742011401. Its NADAC has been published 386 times since May 15, 2019.
FDA first approved this application on Dec 26, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Ingenus Pharmaceuticals LLCNDC
50742011401
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DESIPRAMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204963FDA Approved
12/26/2017
TE Code
AB
On Market Since
9/19/2018
Pharmacological Classes
Price Statistics
The NADAC for DESIPRAMINE 50 MG TABLET has been published 386 times since May 15, 2019, and over the history we have for it it has declined 87.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2177 per EA |
|---|---|
| All-time high | $1.7620 (Jun 12, 2019) |
| All-time low | $0.1847 (May 20, 2026) |
| 52-week high | $0.3211 |
| 52-week low | $0.1847 |
| Median price | $0.3585 |
| Average price | $0.6058 |
| Largest weekly change | +75.6% (Feb 17, 2021) |
| Weeks tracked | 386 |
| Tracking since | May 15, 2019 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ingenus Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
desipramine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Tricyclic Antidepressant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DESIPRAMINE 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DESIPRAMINE 50 MG TABLET, manufactured by Ingenus Pharmaceuticals LLC, is $0.2177 per EA (NDC 50742011401), effective Sep 30, 2026.
How has the price of DESIPRAMINE 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for DESIPRAMINE 50 MG TABLET has declined 87.6%. It has been tracked across 386 weekly CMS publications since May 15, 2019.
What are the highest and lowest recorded NADAC prices for DESIPRAMINE 50 MG TABLET?
Since May 15, 2019, the NADAC for DESIPRAMINE 50 MG TABLET has ranged from a low of $0.1847 (May 20, 2026) to a high of $1.7620 (Jun 12, 2019), with a median of $0.3585 per EA.
Are there cheaper alternatives to DESIPRAMINE 50 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DESIPRAMINE 50 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures DESIPRAMINE 50 MG TABLET?
DESIPRAMINE 50 MG TABLET (NDC 50742011401) is labeled by Ingenus Pharmaceuticals LLC, and CMS classifies it as a generic product.